EHR

Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch

Strong Eversense® 365 early launch indicators illustrated by largest number of new patient shipments and largest number of prescribing providers…

1 year ago

Major shareholder announcement – AIM International Mutual Funds

ANNOUNCEMENT NO. 287 9 December 2024 Major shareholder announcement Major shareholder announcement – AIM International Mutual Funds          Pursuant to…

1 year ago

Major shareholder announcement – Invesco Ltd.

ANNOUNCEMENT NO. 286 9 December 2024 Major shareholder announcement Major shareholder announcement – Invesco Ltd.          Pursuant to Section 30…

1 year ago

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting

– Interim analysis from Phase 1a portion of KOMET-007 shows 100% CR rate in NPM1-m and 83% CR rate in…

1 year ago

New Combination Data of Secura Bio’s COPIKTRA® (duvelisib) Presented at the 2024 American Society of Hematology Meeting

Dr. Alison Moskowitz presented results of a Phase 1 study of combination duvelisib plus ruxolitinib in relapsed/refractory (R/R) peripheral T-cell…

1 year ago

Data Protection as a Service Market worth $74.91 billion by 2030- Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Dec. 6, 2024 /PRNewswire/ -- The global Data Protection as a Service Market will grow to USD…

1 year ago

Medscape and HIMSS Release 2024 Report on AI Adoption in Healthcare

New Study Reveals Current State and Future Expectations of Artificial Intelligence in Healthcare NEWARK, N.J., Dec. 6, 2024 /PRNewswire/ --…

1 year ago

Greenway Health Joins the AWS Partner Network to Accelerate Healthcare Technology Innovation

The collaboration enhances Greenway's ambulatory solutions and paves the way for full cloud migration TAMPA, Fla., Dec. 5, 2024 /PRNewswire/…

1 year ago

Sage Secures $35 Million in Series B Funding to Transform Senior Living Operations Across the U.S. and Beyond

NEW YORK, Dec. 5, 2024 /PRNewswire/ -- Sage, the leading operations management platform for senior living, has raised $35 million…

1 year ago

IceCure’s ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study Results

Data confirm previous results showing that ProSense® cryoablation is highly effective for kidney tumors < 3 cm and a safe…

1 year ago